— Receives New Designation for Treatment of Platelet-Activating Anti-Platelet Factor 4 (PF4) Disorders — Complements FDA Orphan Drug Designation and Fast Track Designation for VLX-1005 Source: Veralox Frederick, MD, Aug. … Read more
WDAdmin
By Anna Eyler In a rapidly evolving business landscape, startups that don’t consider implementing emerging technologies like artificial intelligence (AI) and robotics into their operations are at risk of being … Read more
By Anna Eyler Circular business practices revolutionize industries, mitigate environmental impact, minimize waste generation, achieve cost reductions, and drive sustainable innovation for a brighter future. In a circular economy, materials … Read more
